Viviane Lima

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. ncbi Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART
    Robert S Hogg
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS Med 3:e356. 2006
  2. ncbi Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
    Viviane D Lima
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    AIDS 21:685-92. 2007
  3. ncbi Computerized adaptive testing in back pain: validation of the CAT-5D-QOL
    Jacek A Kopec
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada
    Spine (Phila Pa 1976) 33:1384-90. 2008
  4. ncbi Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, British Columbia, Canada
    J Infect Dis 198:59-67. 2008
  5. ncbi Development and validation of a composite programmatic assessment tool for HIV therapy
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS ONE 7:e47859. 2012
  6. ncbi Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users
    Viviane Dias Lima
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    AIDS 26:1491-500. 2012
  7. ncbi HIV/AIDS in Vancouver, British Columbia: a growing epidemic
    Colin W McInnes
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
    Harm Reduct J 6:5. 2009
  8. ncbi Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
    Siavash Jafari
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
    AIDS Res Ther 8:31. 2011
  9. ncbi Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients
    Viviane Lima
    HIV AIDS Drug Treatment Program, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
    Soc Sci Med 68:1044-9. 2009
  10. ncbi Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS ONE 5:e10991. 2010

Collaborators

Detail Information

Publications33

  1. ncbi Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART
    Robert S Hogg
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS Med 3:e356. 2006
    ..The objective of this study was to determine the impact of the emergence of drug-resistance mutations on survival among persons initiating HAART...
  2. ncbi Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
    Viviane D Lima
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    AIDS 21:685-92. 2007
    ..To characterize the temporal changes in mortality and life expectancy among HIV-positive individuals initiating antiretroviral therapy in British Columbia, Canada, from 1993 to 2004...
  3. ncbi Computerized adaptive testing in back pain: validation of the CAT-5D-QOL
    Jacek A Kopec
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada
    Spine (Phila Pa 1976) 33:1384-90. 2008
    ..We have conducted an outcome instrument validation study...
  4. ncbi Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, British Columbia, Canada
    J Infect Dis 198:59-67. 2008
    ..These results provide powerful additional motivation to accelerate the roll out of HAART programs aggressively targeting those in medical need, both for their own benefit and as a means of decreasing new HIV infections...
  5. ncbi Development and validation of a composite programmatic assessment tool for HIV therapy
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS ONE 7:e47859. 2012
    ..We hypothesized that non-compliance would be associated with the highest probability of mortality...
  6. ncbi Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users
    Viviane Dias Lima
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    AIDS 26:1491-500. 2012
    ..We compared HAART regimens containing efavirenz and boosted atazanavir. We developed logistic regression models using different techniques to control for potential confounders...
  7. ncbi HIV/AIDS in Vancouver, British Columbia: a growing epidemic
    Colin W McInnes
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
    Harm Reduct J 6:5. 2009
    ..These results suggest that HIV infection is having a relatively large impact in Vancouver and that evidence-based prevention and harm reduction strategies should be expanded...
  8. ncbi Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
    Siavash Jafari
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
    AIDS Res Ther 8:31. 2011
    ..abstract:..
  9. ncbi Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients
    Viviane Lima
    HIV AIDS Drug Treatment Program, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
    Soc Sci Med 68:1044-9. 2009
    ..These results suggest that proactive strategies are needed to ensure that antiretroviral therapy remains available on a continued basis to highly migrant populations...
  10. ncbi Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    PLoS ONE 5:e10991. 2010
    ..Here, we explored the potential impact of different HAART coverage scenarios, based on the new guidelines, on the HIV-related incidence, morbidity and mortality in BC, Canada...
  11. ncbi The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada
    J Acquir Immune Defic Syndr 50:529-36. 2009
    ..To characterize the impact of longitudinal adherence on survival in drug-naive individuals starting currently recommended highly active antiretroviral therapy (HAART) regimens...
  12. ncbi Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    J Acquir Immune Defic Syndr 55:460-5. 2010
    ..To model the effect of adherence and duration of viral suppression on the risk of viral rebound...
  13. ncbi Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005
    Viviane D Lima
    HIV AIDS Drug Treatment Program, BC Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, BC V6Z 1Y6
    Can J Public Health 101:44-9. 2010
    ..To examine regional and temporal trends in migration among patients receiving HIV treatment in British Columbia (BC)...
  14. ncbi The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, Canada
    AIDS 21:1175-83. 2007
    ..To determine the impact of depressive symptoms on mortality among HIV/AIDS patients first initiating HAART and the potential role of patient adherence as a confounder and effect modifier in this association...
  15. ncbi Epidemiology of antiretroviral multiclass resistance
    Viviane D Lima
    St Paul s Hospital, 1081 Burrard Street, Room 608, Vancouver, British Columbia V6Z 1Y6, Canada
    Am J Epidemiol 172:460-8. 2010
    ....
  16. ncbi Differential impact of adherence on long-term treatment response among naive HIV-infected individuals
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    AIDS 22:2371-80. 2008
    ....
  17. ncbi Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes
    Julio S G Montaner
    BC Centre for Excellence in HIV AIDS, Providence Health Care, Vancouver, British Columbia, Canada
    J Acquir Immune Defic Syndr 55:S5-9. 2010
    ....
  18. ncbi Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection
    Vikram S Gill
    BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
    Clin Infect Dis 50:98-105. 2010
    ....
  19. ncbi Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation
    Mark W Hull
    Canadian HIV Trials Network, Vancouver, Canada
    J Clin Pharmacol 49:155-61. 2009
    ....
  20. ncbi Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression
    David M Moore
    Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    J Acquir Immune Defic Syndr 52:357-63. 2009
    ..However, the effects of immunologic responses, whether measured as CD4 count changes from baseline or CD4 counts at follow-up, in patients with virologic suppression, have not been clearly established...
  21. ncbi Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, British Columbia, Canada
    J Infect Dis 198:51-8. 2008
    ..We explore the temporal and regimen-specific changes of HIV-1 drug resistance in a large cohort of antiretroviral-naive individuals starting highly active antiretroviral therapy (HAART)...
  22. ncbi Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients
    Elizabeth Phillips
    British Columbia Centre for Excellence in HIV AIDS, Providence Healthcare, St Paul s Hospital, 667 1081 Burrard Street, Vancouver, BC, Canada
    AIDS 21:1561-8. 2007
    ....
  23. ncbi Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay
    Viviane Lima
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    J Acquir Immune Defic Syndr 51:3-6. 2009
    ..5, with a particular focus on the most clinically relevant region near the lower limit of quantification...
  24. ncbi Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting
    Ruth Joy
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
    J Acquir Immune Defic Syndr 47:500-5. 2008
    ....
  25. ncbi Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency
    P Richard Harrigan
    BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    AIDS 22:2501-8. 2008
    ..Missense mutations in HIV-1 reverse transcriptase are frequently selected in response to therapy; we examined whether silent mutations were also selected for by HIV therapy...
  26. ncbi Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population
    Silvia Guillemi
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
    J Clin Densitom 13:456-61. 2010
    ..Lower BMI was independently associated with low BMD. No correlation was found between abnormal BMD and cumulative exposure to any antiretroviral agents...
  27. ncbi Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
    Julio S G Montaner
    British Columbia Centre for Excellence in HIV AIDS, Providence Health Care, Vancouver, BC, Canada
    Lancet 376:532-9. 2010
    ..We aimed to estimate the association between plasma HIV-1 viral load, HAART coverage, and number of new cases of HIV in the population of a Canadian province...
  28. ncbi Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals
    Viviane D Lima
    British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 667 1081 Burrard St, Vancouver, BC, V6Z 1Y6 Canada
    Am J Public Health 99:S193-6. 2009
    ..We examined the significance of plasma HIV-1 RNA levels (or viral load alone) in predicting CD4 cell decline in untreated HIV-infected individuals...
  29. ncbi Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort
    A M Cescon
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    HIV Med 12:352-60. 2011
    ..The aim of the study was to evaluate time to virological suppression in a cohort of individuals who started highly active antiretroviral therapy (HAART), and to explore the factors associated with suppression...
  30. ncbi Epidemiology of treatment failure: a focus on recent trends
    Mark W Hull
    BC Centre for Excellence in HIV AIDS, Simon Fraser University, Vancouver, British Columbia, Canada
    Curr Opin HIV AIDS 4:467-73. 2009
    ..This review will highlight recent trends in treatment failure and virologic resistance in the developed world and resource-limited settings...
  31. ncbi Does ratification of human-rights treaties have effects on population health?
    Alexis Palmer
    Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada
    Lancet 373:1987-92. 2009
    ....
  32. ncbi Presenting plasma HIV RNA level and rate of CD4 T-cell decline
    Viviane D Lima
    JAMA 297:805-6; author reply 806-7. 2007
  33. ncbi Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply
    Elizabeth Phillips
    AIDS 22:548-9. 2008